Literature DB >> 15770406

Juvenile hepatocellular carcinoma with congestive liver cirrhosis.

Yuko Izumi1, Naoki Hiramatsu, Ichiyo Itose, Takahiro Inoue, Akira Sasagawa, Satoshi Egawa, Tsutomu Nishida, Yoshimi Kakiuchi, Takashi Toyama, Fumihiko Nakanishi, Kazuyoshi Ohkawa, Kiyoshi Mochizuki, Tatsuya Kanto, Masahiko Tsujii, Tetsuo Takehara, Shingo Tsuji, Michio Kato, Akinori Kasahara, Norio Hayashi.   

Abstract

A case of juvenile hepatocellular carcinoma (HCC) with congestive liver cirrhosis is reported. The patient was a 21-year-old woman. She had been diagnosed as having transposition of the great arteries, type 2, in 1978. She underwent the Mustard operation, but suffered from chronic heart failure. In 1995, she experienced abdominal pain and underwent examination. The laboratory data were normal, except for elevated total bilirubin (5.2 mg/dl). Blood examinations were performed at frequent intervals, and the total bilirubin level fluctuated between 0.9 and 8.1 mg/dl over the next 4 years, but the transaminase level remained normal. In 1999, she experienced abdominal pain again and was admitted to our hospital. Computed tomography showed four space-occupying lesions in the liver; 45 mm, 20 mm, 12 mm, and 10 mm in size. She was diagnosed as having HCC, and transcatheter arterial chemoembolization and percutaneous ethanol injection therapy were performed. Histology of the cancerous and the noncancerous liver tissue revealed HCC, moderately differentiated type, in cirrhotic liver with congestion. This patient had no background factors of liver disease, except for liver congestion, associated with the chronic heart failure. Because most patients with cardiac cirrhosis die of cardiac disease, only a small number of these patients develop liver failure. However, the incidence of HCC in patients with congestive liver disease is likely to increase in the future, as survival time is prolonged with the advances in treatment for chronic heart failure. Therefore, patients with congestive liver disease should be followed, taking into account the possibility of HCC.

Entities:  

Mesh:

Year:  2005        PMID: 15770406     DOI: 10.1007/s00535-004-1525-4

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  6 in total

1.  Surveillance for hepatocellular carcinoma secondary to cardiogenic cirrhosis in patients with congenital heart disease.

Authors:  Alexander Augustyn; Lan Peng; Amit G Singal; Adam C Yopp
Journal:  Clin Res Cardiol       Date:  2015-01-21       Impact factor: 5.460

2.  Hepatic pathology after Fontan palliation: spectrum of imaging findings.

Authors:  Daniel B Wallihan; Daniel J Podberesky
Journal:  Pediatr Radiol       Date:  2012-10-06

3.  Development of hepatocellular carcinoma in cardiac congestive liver fibrosis: report of a case.

Authors:  Koichiro Ohashi; Yuji Iimuro; Kazuhiro Suzumura; Seikan Hai; Shogo Tanaka; Tadamichi Hirano; Hideaki Sueoka; Seiichi Hirota; Jiro Fujimoto
Journal:  Clin J Gastroenterol       Date:  2015-04-09

4.  Surgical management of hepatocellular carcinoma after Fontan procedure.

Authors:  Steve Kwon; Lauren Scovel; Matthew Yeh; David Dorsey; Gregory Dembo; Eric V Krieger; Ramassmy Bakthavatsalam; James O Park; Kevin M Riggle; Kimberly J Riehle; Raymond S Yeung
Journal:  J Gastrointest Oncol       Date:  2015-06

5.  Hepatic changes in the failing Fontan circulation.

Authors:  Christoph H Kiesewetter; Nick Sheron; Joseph J Vettukattill; Nigel Hacking; Brian Stedman; Harry Millward-Sadler; Marcus Haw; Richard Cope; Anthony P Salmon; Muthukumaran C Sivaprakasam; Tim Kendall; Barry R Keeton; John P Iredale; Gruschen R Veldtman
Journal:  Heart       Date:  2006-09-27       Impact factor: 5.994

6.  Does pressure cause liver cirrhosis? The sinusoidal pressure hypothesis.

Authors:  Sebastian Mueller
Journal:  World J Gastroenterol       Date:  2016-12-28       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.